Literature DB >> 17206149

Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract.

J M Nicholls1, M C W Chan, W Y Chan, H K Wong, C Y Cheung, D L W Kwong, M P Wong, W H Chui, L L M Poon, S W Tsao, Y Guan, J S M Peiris.   

Abstract

Poor human-to-human transmission of influenza A H5N1 virus has been attributed to the paucity of putative sialic acid alpha2-3 virus receptors in the epithelium of the human upper respiratory tract, and thus to the presumed inability of the virus to replicate efficiently at this site. We now demonstrate that ex vivo cultures of human nasopharyngeal, adenoid and tonsillar tissues can be infected with H5N1 viruses in spite of an apparent lack of these receptors.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17206149     DOI： 10.1038/nm1529

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


  154 in total

1.  Human pulmonary microvascular endothelial cells support productive replication of highly pathogenic avian influenza viruses: possible involvement in the pathogenesis of human H5N1 virus infection.

Authors:  Hui Zeng; Claudia Pappas; Jessica A Belser; Katherine V Houser; Weiming Zhong; Debra A Wadford; Troy Stevens; Ron Balczon; Jacqueline M Katz; Terrence M Tumpey
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

Review 2.  Emerging Infections of CNS: Avian Influenza A Virus, Rift Valley Fever Virus and Human Parechovirus.

Authors:  Clayton A Wiley; Nitin Bhardwaj; Ted M Ross; Stephanie J Bissel
Journal:  Brain Pathol       Date:  2015-09       Impact factor: 6.508

3.  Influenza A Virus Reassortment Is Limited by Anatomical Compartmentalization following Coinfection via Distinct Routes.

Authors:  Mathilde Richard; Sander Herfst; Hui Tao; Nathan T Jacobs; Anice C Lowen
Journal:  J Virol       Date:  2018-02-12       Impact factor: 5.103

Review 4.  Pathology of human influenza revisited.

Authors:  Thijs Kuiken; Jeffery K Taubenberger
Journal:  Vaccine       Date:  2008-09-12       Impact factor: 3.641

Review 5.  Pathogenicity of highly pathogenic avian influenza virus in mammals.

Authors:  Emmie de Wit; Yoshihiro Kawaoka; Menno D de Jong; Ron A M Fouchier
Journal:  Vaccine       Date:  2008-09-12       Impact factor: 3.641

6.  Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals.

Authors:  Debby van Riel; Vincent J Munster; Emmie de Wit; Guus F Rimmelzwaan; Ron A M Fouchier; Albert D M E Osterhaus; Thijs Kuiken
Journal:  Am J Pathol       Date:  2007-08-23       Impact factor: 4.307

7.  Design and validation of an H5 TaqMan real-time one-step reverse transcription-PCR and confirmatory assays for diagnosis and verification of influenza A virus H5 infections in humans.

Authors:  Joanna S Ellis; Joanne W Smith; Sharleen Braham; Matthew Lock; Katrina Barlow; Maria C Zambon
Journal:  J Clin Microbiol       Date:  2007-03-14       Impact factor: 5.948

8.  Tropism and infectivity of influenza virus, including highly pathogenic avian H5N1 virus, in ferret tracheal differentiated primary epithelial cell cultures.

Authors:  Hui Zeng; Cynthia S Goldsmith; Taronna R Maines; Jessica A Belser; Kortney M Gustin; Andrew Pekosz; Sherif R Zaki; Jacqueline M Katz; Terrence M Tumpey
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

9.  Pathogenesis of 1918 pandemic and H5N1 influenza virus infections in a guinea pig model: antiviral potential of exogenous alpha interferon to reduce virus shedding.

Authors:  Neal Van Hoeven; Jessica A Belser; Kristy J Szretter; Hui Zeng; Peter Staeheli; David E Swayne; Jacqueline M Katz; Terrence M Tumpey
Journal:  J Virol       Date:  2009-01-14       Impact factor: 5.103

10.  Analysis of N-glycans in embryonated chicken egg chorioallantoic and amniotic cells responsible for binding and adaptation of human and avian influenza viruses.

Authors:  Nongluk Sriwilaijaroen; Sachiko Kondo; Hirokazu Yagi; Prapon Wilairat; Hiroaki Hiramatsu; Morihiro Ito; Yasuhiko Ito; Koichi Kato; Yasuo Suzuki
Journal:  Glycoconj J       Date:  2008-10-14       Impact factor: 2.916
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.